Skip to main content
Top
Published in: Clinical Research in Cardiology 5/2019

Open Access 01-05-2019 | Original Paper

Mode of presentation and mortality amongst patients hospitalized with heart failure? A report from the First Euro Heart Failure Survey

Authors: Ahmad Shoaib, M. Farag, J. Nolan, A. Rigby, A. Patwala, M. Rashid, C. S. Kwok, R. Perveen, A. L. Clark, M. Komajda, J. G. F. Cleland

Published in: Clinical Research in Cardiology | Issue 5/2019

Login to get access

Abstract

Background

Heart failure is heterogeneous in aetiology, pathophysiology, and presentation. Despite this diversity, clinical trials of patients hospitalized for HF deal with this problem as a single entity, which may be one reason for repeated failures.

Methods

The first EuroHeart Failure Survey screened consecutive deaths and discharges of patients with suspected heart failure during 2000–2001. Patients were sorted into seven mutually exclusive hierarchical presentations: (1) with cardiac arrest/ventricular arrhythmia; (2) with acute coronary syndrome; (3) with rapid atrial fibrillation; (4) with acute breathlessness; (5) with other symptoms/signs such as peripheral oedema; (6) with stable symptoms; and (7) others in whom the contribution of HF to admission was not clear.

Results

The 10,701 patients enrolled were classified into the above seven presentations as follows: 260 (2%), 560 (5%), 799 (8%), 2479 (24%), 1040 (10%), 703 (7%), and 4691 (45%) for which index-admission mortality was 26%, 20%, 10%, 8%, 6%, 6%, and 4%, respectively. Compared to those in group 7, the hazard ratios for death during the index admission were 4.9 (p ≤ 0.001), 4.0 (p < 0.001), 2.2 (p < 0.001), 2.1 (p < 0.001), 1.4 (p < 0.04) and 1.4 (p = 0.04), respectively. These differences were no longer statistically significant by 12 weeks.

Conclusion

There is great diversity in the presentation of heart failure that is associated with very different short-term outcomes. Only a minority of hospitalizations associated with suspected heart failure are associated with acute breathlessness. This should be taken into account in the design of future clinical trials.
Literature
1.
go back to reference Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA et al (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10(10):933–989CrossRefPubMed Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA et al (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10(10):933–989CrossRefPubMed
2.
go back to reference McDonagh TA, Komajda M, Maggioni AP, Zannad F, Gheorghiade M, Metra M et al (2011) Clinical trials in acute heart failure: simpler solutions to complex problems. Consensus document arising from a European Society of Cardiology cardiovascular round-table think tank on acute heart failure, 12 May 2009. Eur J Heart Fail 13(12):1253–1260CrossRefPubMed McDonagh TA, Komajda M, Maggioni AP, Zannad F, Gheorghiade M, Metra M et al (2011) Clinical trials in acute heart failure: simpler solutions to complex problems. Consensus document arising from a European Society of Cardiology cardiovascular round-table think tank on acute heart failure, 12 May 2009. Eur J Heart Fail 13(12):1253–1260CrossRefPubMed
4.
go back to reference Shoaib A, Mabote T, Zuhair M, Kassianides X, Cleland J (2013) Acute heart failure (suspected or confirmed): initial diagnosis and subsequent evaluation with traditional and novel technologies. World J Cardiovasc Dis 3(3):290–300CrossRef Shoaib A, Mabote T, Zuhair M, Kassianides X, Cleland J (2013) Acute heart failure (suspected or confirmed): initial diagnosis and subsequent evaluation with traditional and novel technologies. World J Cardiovasc Dis 3(3):290–300CrossRef
5.
go back to reference Sze S, Zhang J, Pellicori P, Morgan D, Hoye A, Clark AL (2017) Prognostic value of simple frailty and malnutrition screening tools in patients with acute heart failure due to left ventricular systolic dysfunction. Clin Res Cardiol 106(7):533–541CrossRefPubMed Sze S, Zhang J, Pellicori P, Morgan D, Hoye A, Clark AL (2017) Prognostic value of simple frailty and malnutrition screening tools in patients with acute heart failure due to left ventricular systolic dysfunction. Clin Res Cardiol 106(7):533–541CrossRefPubMed
6.
go back to reference Clark AL, Cleland JG (2013) Causes and treatment of oedema in patients with heart failure. Nat Rev Cardiol 10(3):156–170CrossRefPubMed Clark AL, Cleland JG (2013) Causes and treatment of oedema in patients with heart failure. Nat Rev Cardiol 10(3):156–170CrossRefPubMed
7.
go back to reference Miro O, Gil V, Xipell C, Sanchez C, Aguilo S, Martin-Sanchez FJ et al (2017) IMPROV-ED study: outcomes after discharge for an episode of acute-decompensated heart failure and comparison between patients discharged from the emergency department and hospital wards. Clin Res Cardiol 106(5):369–378CrossRefPubMed Miro O, Gil V, Xipell C, Sanchez C, Aguilo S, Martin-Sanchez FJ et al (2017) IMPROV-ED study: outcomes after discharge for an episode of acute-decompensated heart failure and comparison between patients discharged from the emergency department and hospital wards. Clin Res Cardiol 106(5):369–378CrossRefPubMed
8.
go back to reference Allen LA, Hernandez AF, O’Connor CM, Felker GM (2009) End points for clinical trials in acute heart failure syndromes. J Am Coll Cardiol 53(24):2248–2258CrossRefPubMedPubMedCentral Allen LA, Hernandez AF, O’Connor CM, Felker GM (2009) End points for clinical trials in acute heart failure syndromes. J Am Coll Cardiol 53(24):2248–2258CrossRefPubMedPubMedCentral
9.
go back to reference Zanolla L, Zardini P (2003) Selection of endpoints for heart failure clinical trials. Eur J Heart Fail 5(6):717–723CrossRefPubMed Zanolla L, Zardini P (2003) Selection of endpoints for heart failure clinical trials. Eur J Heart Fail 5(6):717–723CrossRefPubMed
10.
go back to reference Tamargo J, Rosano GMC, Delpón E, Ruilope L, López-Sendón J (2017) Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes. Int J Cardiol 233:1–11CrossRefPubMed Tamargo J, Rosano GMC, Delpón E, Ruilope L, López-Sendón J (2017) Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes. Int J Cardiol 233:1–11CrossRefPubMed
11.
go back to reference Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC et al (2003) The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24(5):442–463CrossRefPubMed Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC et al (2003) The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24(5):442–463CrossRefPubMed
13.
go back to reference Cleland JG, Swedberg K, Cohen-Solal A, Cosin-Aguilar J, Dietz R, Follath F et al (2000) The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York. Eur J Heart Fail 2(2):123–132CrossRefPubMed Cleland JG, Swedberg K, Cohen-Solal A, Cosin-Aguilar J, Dietz R, Follath F et al (2000) The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York. Eur J Heart Fail 2(2):123–132CrossRefPubMed
14.
go back to reference Sauerbrei W (1999) The use of resampling methods to simplify regression models in medical statistics. J R Stat Soc Ser C Appl Stat 48(3):313–329CrossRef Sauerbrei W (1999) The use of resampling methods to simplify regression models in medical statistics. J R Stat Soc Ser C Appl Stat 48(3):313–329CrossRef
15.
go back to reference Ingle L, Rigby AS, Carroll S, Butterly R, King RF, Cooke CB et al (2007) Prognostic value of the 6 min walk test and self-perceived symptom severity in older patients with chronic heart failure. Eur Heart J 28(5):560–568CrossRefPubMed Ingle L, Rigby AS, Carroll S, Butterly R, King RF, Cooke CB et al (2007) Prognostic value of the 6 min walk test and self-perceived symptom severity in older patients with chronic heart failure. Eur Heart J 28(5):560–568CrossRefPubMed
16.
go back to reference Cleland JG, Chiswell K, Teerlink JR, Stevens S, Fiuzat M, Givertz MM et al (2014) Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study. Circ Heart Fail 7(1):76–87CrossRefPubMed Cleland JG, Chiswell K, Teerlink JR, Stevens S, Fiuzat M, Givertz MM et al (2014) Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study. Circ Heart Fail 7(1):76–87CrossRefPubMed
17.
go back to reference Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148(3):839–843CrossRef Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148(3):839–843CrossRef
18.
go back to reference Shoaib A, Farag M, Nasir M, John J, Gupta S, Pellicori P et al (2016) Is the diagnostic coding position of acute heart failure related to mortality? A report from the Euro Heart Failure Survey-1. Eur J Heart Fail 18(5):556–563CrossRefPubMed Shoaib A, Farag M, Nasir M, John J, Gupta S, Pellicori P et al (2016) Is the diagnostic coding position of acute heart failure related to mortality? A report from the Euro Heart Failure Survey-1. Eur J Heart Fail 18(5):556–563CrossRefPubMed
20.
go back to reference Raftery AE (1995) Bayesian model selection in social research. Sociol Methodol 25:111–163CrossRef Raftery AE (1995) Bayesian model selection in social research. Sociol Methodol 25:111–163CrossRef
21.
go back to reference Miro O, Gil VI, Martin-Sanchez FJ, Jacob J, Herrero P, Alquezar A et al (2018) Short-term outcomes of heart failure patients with reduced and preserved ejection fraction after acute decompensation according to the final destination after emergency department care. Clin Res Cardiol 107(8):698–710CrossRefPubMed Miro O, Gil VI, Martin-Sanchez FJ, Jacob J, Herrero P, Alquezar A et al (2018) Short-term outcomes of heart failure patients with reduced and preserved ejection fraction after acute decompensation according to the final destination after emergency department care. Clin Res Cardiol 107(8):698–710CrossRefPubMed
22.
go back to reference Felker GM, Adams KF, Konstam MA, O’Connor CM, Gheorghiade M (2003) The problem of decompensated heart failure: nomenclature, classification, and risk stratification. Am Heart J 145(2):S18–S25CrossRefPubMed Felker GM, Adams KF, Konstam MA, O’Connor CM, Gheorghiade M (2003) The problem of decompensated heart failure: nomenclature, classification, and risk stratification. Am Heart J 145(2):S18–S25CrossRefPubMed
23.
go back to reference Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA et al (2005) Acute heart failure syndromes current state framework for future research. Circulation 112(25):3958–3968CrossRefPubMed Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA et al (2005) Acute heart failure syndromes current state framework for future research. Circulation 112(25):3958–3968CrossRefPubMed
24.
go back to reference Shoaib A, Waleed M, Khan S, Raza A, Zuhair M, Kassianides X et al (2014) Breathlessness at rest is not the dominant presentation of patients admitted with heart failure. Eur J Heart Fail 16:1283–1291CrossRefPubMed Shoaib A, Waleed M, Khan S, Raza A, Zuhair M, Kassianides X et al (2014) Breathlessness at rest is not the dominant presentation of patients admitted with heart failure. Eur J Heart Fail 16:1283–1291CrossRefPubMed
25.
go back to reference Gimpelewicz C, Metra M, Cleland JGF, Szecsody P, Chang Wun CC, Boer-Martins L et al (2017) Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: a subgroup analysis from the RELAX-AHF trial. Am Heart J 190:113–122CrossRefPubMed Gimpelewicz C, Metra M, Cleland JGF, Szecsody P, Chang Wun CC, Boer-Martins L et al (2017) Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: a subgroup analysis from the RELAX-AHF trial. Am Heart J 190:113–122CrossRefPubMed
26.
go back to reference Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352(15):1539–1549CrossRefPubMed Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352(15):1539–1549CrossRefPubMed
27.
go back to reference CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 316(23):1429–1435CrossRef CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 316(23):1429–1435CrossRef
28.
go back to reference Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341(10):709–717CrossRefPubMed Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341(10):709–717CrossRefPubMed
29.
go back to reference McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787–1847CrossRef McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787–1847CrossRef
30.
go back to reference Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Rev Esp Cardiol (English ed) 69(12):1167 Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Rev Esp Cardiol (English ed) 69(12):1167
31.
go back to reference Tamargo J, Rosano GMC, Delpón E, Ruilope L, López-Sendón J (2016) Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes. Int J Cardiol 233:1–11CrossRefPubMed Tamargo J, Rosano GMC, Delpón E, Ruilope L, López-Sendón J (2016) Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes. Int J Cardiol 233:1–11CrossRefPubMed
32.
go back to reference Teichman SL, Maisel AS, Storrow AB (2015) Challenges in acute heart failure clinical management: optimizing care despite incomplete evidence and imperfect drugs. Crit Pathw Cardiol 14(1):12–24CrossRefPubMedPubMedCentral Teichman SL, Maisel AS, Storrow AB (2015) Challenges in acute heart failure clinical management: optimizing care despite incomplete evidence and imperfect drugs. Crit Pathw Cardiol 14(1):12–24CrossRefPubMedPubMedCentral
33.
go back to reference Pang PS, Givertz MM (2013) The challenge of drug development in acute heart failure. Balancing mechanisms, targeting patients, and gambling on outcomes. JCHF 1(5):442–444 Pang PS, Givertz MM (2013) The challenge of drug development in acute heart failure. Balancing mechanisms, targeting patients, and gambling on outcomes. JCHF 1(5):442–444
34.
go back to reference Palazzuoli A, Ruocco G, Beltrami M, Nuti R, Cleland JG (2018) Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF. Clin Res Cardiol 107(7):586–596CrossRefPubMed Palazzuoli A, Ruocco G, Beltrami M, Nuti R, Cleland JG (2018) Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF. Clin Res Cardiol 107(7):586–596CrossRefPubMed
35.
go back to reference Shoaib A, Raza A, Waleed M, Djahit A, Kassianides X et al (2013) Presenting symptoms and changes in heart and respiratory rate and blood pressure in the first 24 hours after admission in patients admitted with heart failure. ESC Heart Fail 16:1283–1291CrossRef Shoaib A, Raza A, Waleed M, Djahit A, Kassianides X et al (2013) Presenting symptoms and changes in heart and respiratory rate and blood pressure in the first 24 hours after admission in patients admitted with heart failure. ESC Heart Fail 16:1283–1291CrossRef
36.
go back to reference Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD (2012) Third universal definition of myocardial infarction. Circulation 126(16):2020–2035CrossRef Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD (2012) Third universal definition of myocardial infarction. Circulation 126(16):2020–2035CrossRef
37.
go back to reference Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F et al (2016) 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 37(3):267–315CrossRef Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F et al (2016) 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 37(3):267–315CrossRef
38.
go back to reference Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA et al (2012) ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33(20):2569–2619CrossRefPubMed Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA et al (2012) ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33(20):2569–2619CrossRefPubMed
39.
go back to reference Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JG et al (2014) Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet 384(9961):2235–2243CrossRefPubMed Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JG et al (2014) Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet 384(9961):2235–2243CrossRefPubMed
40.
go back to reference Mebazaa A, Pang PS, Tavares M, Collins SP, Storrow AB, Laribi S et al (2010) The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study. Eur Heart J 31(7):832–841CrossRefPubMed Mebazaa A, Pang PS, Tavares M, Collins SP, Storrow AB, Laribi S et al (2010) The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study. Eur Heart J 31(7):832–841CrossRefPubMed
41.
go back to reference Gray A, Goodacre S, Newby DE, Masson M, Sampson F, Nicholl J (2008) Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med 359(2):142–151CrossRefPubMed Gray A, Goodacre S, Newby DE, Masson M, Sampson F, Nicholl J (2008) Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med 359(2):142–151CrossRefPubMed
42.
go back to reference Riedel O, Ohlmeier C, Enders D, Elsasser A, Vizcaya D, Michel A et al (2018) The contribution of comorbidities to mortality in hospitalized patients with heart failure. Clin Res Cardiol 107(6):487–497CrossRefPubMed Riedel O, Ohlmeier C, Enders D, Elsasser A, Vizcaya D, Michel A et al (2018) The contribution of comorbidities to mortality in hospitalized patients with heart failure. Clin Res Cardiol 107(6):487–497CrossRefPubMed
43.
go back to reference Passantino A, Monitillo F, Iacoviello M, Scrutinio D (2015) Predicting mortality in patients with acute heart failure: role of risk scores. World J Cardiol 7(12):902–911CrossRefPubMedPubMedCentral Passantino A, Monitillo F, Iacoviello M, Scrutinio D (2015) Predicting mortality in patients with acute heart failure: role of risk scores. World J Cardiol 7(12):902–911CrossRefPubMedPubMedCentral
44.
go back to reference O’Connor CM, Abraham WT, Albert NM, Clare R, Gattis Stough W, Gheorghiade M et al (2008) Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 156(4):662–673CrossRefPubMed O’Connor CM, Abraham WT, Albert NM, Clare R, Gattis Stough W, Gheorghiade M et al (2008) Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 156(4):662–673CrossRefPubMed
Metadata
Title
Mode of presentation and mortality amongst patients hospitalized with heart failure? A report from the First Euro Heart Failure Survey
Authors
Ahmad Shoaib
M. Farag
J. Nolan
A. Rigby
A. Patwala
M. Rashid
C. S. Kwok
R. Perveen
A. L. Clark
M. Komajda
J. G. F. Cleland
Publication date
01-05-2019
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 5/2019
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-018-1380-6

Other articles of this Issue 5/2019

Clinical Research in Cardiology 5/2019 Go to the issue